Data / Drug companies / Vivunt Pharma LLC
Vivunt Pharma LLC: 31 products in the FDA NDC directory, labeler code 82706
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Vivunt Pharma LLC (labeler code 82706) lists 31 products in the FDA National Drug Code Directory, covering 14 finished drugs by generic name. By type: 31 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on August 1, 2026.
The request: Watch Vivunt Pharma LLC (FDA labeler code 82706): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 82706
- Products in commercial distribution
- 31
- Packages
- 47
- Finished drugs by generic name
- 14
- Prescription products
- 0
- Over the counter products
- 31
- Flagged as original packager
- 31 of 31 products that carry the flag
- Started marketing in the last 12 months
- 11
- Earliest marketing start
- May 9, 2022
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 30 | 96.8% |
| Generic drugs (ANDA) | 1 | 3.2% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 31 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Acetaminophen, dextromethorphan hydrobromide | 3 | 20 |
| Diphenhydramine hydrochloride | 3 | 127 |
| Oxymetazoline hydrochloride. | 3 | 1 |
| Calcium carbonate | 2 | 101 |
| Dextromethorphan hydrobromide, guaifenesin | 2 | 49 |
| Acetaminophen | 2 | 214 |
| Simethicone | 2 | 86 |
| Bismuth subsalicylate | 2 | 80 |
| Acetaminophen, guaifenesin, phenylephrine hydrocloride | 1 | 1 |
| Acetaminophen, phenylephrine hydrochloride | 1 | 6 |
| Ibuprofen | 1 | 190 |
| Acetaminophen, diphenhydramine hydrochloride | 1 | 14 |
| Acetaminophen, caffeine | 1 | 14 |
| Docusate sodium | 1 | 79 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule, liquid filled | 12 | 38.7% |
| Liquid | 6 | 19.4% |
| Tablet | 5 | 16.1% |
| Kit | 3 | 9.7% |
| Tablet, chewable | 2 | 6.5% |
| Aerosol, spray | 2 | 6.5% |
| Spray | 1 | 3.2% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Ibuprofen Minis | 82706-032 | Capsule, liquid filled | Generic drugs (ANDA) | August 1, 2026 |
| FEVIA Gas Control | 82706-031 | Capsule, liquid filled | Over the counter monograph drugs | February 19, 2026 |
| FEVIA Gas Control | 82706-031 | Capsule, liquid filled | Over the counter monograph drugs | February 19, 2026 |
| FEVIA Constipation Control | 82706-029 | Capsule, liquid filled | Over the counter monograph drugs | February 19, 2026 |
| FEVIA Diarrhea Control | 82706-028 | Capsule, liquid filled | Over the counter monograph drugs | February 18, 2026 |
| FEVIA Diarrhea Control | 82706-028 | Capsule, liquid filled | Over the counter monograph drugs | February 18, 2026 |
| FEVIA Acid Control | 82706-027 | Tablet, chewable | Over the counter monograph drugs | February 18, 2026 |
| FEVIA Acid Control | 82706-027 | Tablet, chewable | Over the counter monograph drugs | February 18, 2026 |
| AXIV Sinus OVERNIGHT | 82706-034 | Spray | Over the counter monograph drugs | January 19, 2026 |
| AXIV Sinus Severe Ultra Fine Mist | 82706-030 | Aerosol, spray | Over the counter monograph drugs | January 19, 2026 |
| Sinus Severe Ultra Fine Mist | 82706-026 | Aerosol, spray | Over the counter monograph drugs | January 19, 2026 |
| Sinus Head Congestion | 82706-025 | Capsule, liquid filled | Over the counter monograph drugs | March 18, 2025 |
| AXIV Allergy Relief | 82706-021 | Tablet | Over the counter monograph drugs | July 9, 2024 |
| AXIV DM Max | 82706-024 | Liquid | Over the counter monograph drugs | May 14, 2024 |
| AXIV Night Time - Liquid | 82706-023 | Liquid | Over the counter monograph drugs | May 14, 2024 |
| AXIV DayTime - Liquid | 82706-022 | Liquid | Over the counter monograph drugs | May 14, 2024 |
| AXIV Sinus Severe Mucus | 82706-020 | Capsule, liquid filled | Over the counter monograph drugs | March 8, 2024 |
| AXIV Allergy | 82706-019 | Capsule, liquid filled | Over the counter monograph drugs | March 8, 2024 |
| AXIV DayTime - NightTime 72 Softgels | 82706-018 | Kit | Over the counter monograph drugs | March 8, 2024 |
| AXIV DayTime - NightTime 48 Softgels | 82706-017 | Kit | Over the counter monograph drugs | March 8, 2024 |
| AXIV NightTime | 82706-016 | Capsule, liquid filled | Over the counter monograph drugs | March 7, 2024 |
| AXIV DayTime | 82706-015 | Capsule, liquid filled | Over the counter monograph drugs | March 7, 2024 |
| AXIV - VroZzz | 82706-014 | Capsule, liquid filled | Over the counter monograph drugs | March 7, 2024 |
| AXIM DM Max | 82706-013 | Liquid | Over the counter monograph drugs | January 5, 2024 |
| AXIM Night Time - Liquid | 82706-012 | Liquid | Over the counter monograph drugs | January 5, 2024 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.